Samir Gharib is listed as an executive officer on 3 SEC Form D filings by 1 issuer between Aug 2020 and Oct 2025: SPRUCE BIOSCIENCES, INC. (South San Francisco, CA — biotechnology — 2020–2025; $88M reported sold to 21 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Bali Muralidhar (3 shared filings), Michael Grey (3 shared filings), Tiba Aynechi (3 shared filings), DANIEL K. SPIEGELMAN (2 shared filings), DINA CHAYA (2 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Samir. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Samir Gharib and found 3 differences: Address moved from Daly City, CA to South San Francisco, CA; Address moved from San Francisco, CA to Daly City, CA; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.